COGNICURRENT

Jan 8 • 23:32 UTC • 🇪🇸 Spain • ABC

More than 1 in 4 adults could benefit from new anti-obesity drugs

A study suggests implementing strategic programs for GLP-1 medications to address the global obesity crisis, while also warning about the rebound effect of drugs like Ozempic.

#obesity #health #drugs #glp-1 #world

Read Original Back to Feed

📡 Similar Coverage

🇭🇷 Croatia Jan 4 • 12:38 UTC

Are Ozempic and similar weight loss drugs becoming lifelong therapy?

Index.hr

🇭🇷 Croatia Jan 5 • 12:53 UTC

GLP-1 drugs spur the biggest change in the packaged food industry in years

Index.hr

🇫🇷 France Dec 26 • 13:59 UTC

Ozempic craze: Approved for diabetes, growing use in obesity

France24

🇭🇷 Croatia Jan 5 • 12:53 UTC

New Products: How Medications Like Ozempic are Changing the Food Industry

Index.hr

🇪🇸 Spain Jan 8 • 10:55 UTC

The rebound effect of Ozempic-type drugs: patients regain weight in less than two years

ABC

🇮🇸 Iceland Jan 8 • 08:23 UTC

Weight loss with medications will revert much faster after ceasing use

Visir